Medexus Pharmaceuticals Balans Gezondheid
Financiële gezondheid criteriumcontroles 3/6
Medexus Pharmaceuticals has a total shareholder equity of $32.6M and total debt of $46.3M, which brings its debt-to-equity ratio to 142.2%. Its total assets and total liabilities are $147.3M and $114.7M respectively. Medexus Pharmaceuticals's EBIT is $12.3M making its interest coverage ratio 1.1. It has cash and short-term investments of $8.5M.
Belangrijke informatie
142.2%
Verhouding schuld/eigen vermogen
US$46.34m
Schuld
| Rente dekkingsratio | 1.1x |
| Contant | US$8.45m |
| Aandelen | US$32.59m |
| Totaal verplichtingen | US$114.68m |
| Totaal activa | US$147.26m |
Recente financiële gezondheidsupdates
Here's Why Medexus Pharmaceuticals (TSE:MDP) Has A Meaningful Debt Burden
Apr 25
Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Sep 11Medexus Pharmaceuticals (TSE:MDP) Use Of Debt Could Be Considered Risky
Jan 19Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Sep 22Is Medexus Pharmaceuticals (TSE:MDP) Weighed On By Its Debt Load?
Dec 16Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Aug 04Recent updates
There May Be Reason For Hope In Medexus Pharmaceuticals' (TSE:MDP) Disappointing Earnings
Aug 19Medexus Pharmaceuticals Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 10Medexus Pharmaceuticals Inc. (TSE:MDP) Shares Fly 29% But Investors Aren't Buying For Growth
Jul 31The Market Doesn't Like What It Sees From Medexus Pharmaceuticals Inc.'s (TSE:MDP) Revenues Yet
Jun 15Here's Why Medexus Pharmaceuticals (TSE:MDP) Has A Meaningful Debt Burden
Apr 25Revenues Working Against Medexus Pharmaceuticals Inc.'s (TSE:MDP) Share Price Following 26% Dive
Mar 03Medexus Pharmaceuticals Inc.'s (TSE:MDP) Shares Leap 89% Yet They're Still Not Telling The Full Story
Jan 06Here's Why Medexus Pharmaceuticals (TSE:MDP) Has Caught The Eye Of Investors
Oct 11Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Sep 11Medexus Pharmaceuticals (TSE:MDP) Use Of Debt Could Be Considered Risky
Jan 19Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Sep 22Is Medexus Pharmaceuticals (TSE:MDP) Weighed On By Its Debt Load?
Dec 16Medexus Pharmaceuticals Inc. (TSE:MDP) Analysts Just Cut Their EPS Forecasts Substantially
Aug 21Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Aug 04Analyse van de financiële positie
Kortlopende schulden: MDP's short term assets ($65.5M) exceed its short term liabilities ($59.2M).
Langlopende schulden: MDP's short term assets ($65.5M) exceed its long term liabilities ($55.4M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: MDP's net debt to equity ratio (116.3%) is considered high.
Schuld verminderen: MDP's debt to equity ratio has increased from 69% to 142.2% over the past 5 years.
Schuldendekking: MDP's debt is well covered by operating cash flow (49%).
Rentedekking: MDP's interest payments on its debt are not well covered by EBIT (1.1x coverage).